FDA.reportPublic FDA data

{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack

RxCUI
1491642
RxNorm name
{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Display name
{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Full name
{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } Pack
Term type
GPCK
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AptiomESLICARBAZEPINE ACETATESumitomo Pharma America, Inc.3d0c9554-eaeb-4694-8089-00133fcadce32023-11-10Warnings, Adverse reactionsExact identifier
rxcui: 1491642

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3d0c9554-eaeb-4694-8089-00133fcadce3{7 (eslicarbazepine acetate 400 MG Oral Tablet) / 7 (eslicarbazepine acetate 800 MG Oral Tablet) } PackGPCK16These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 201320231110
3d0c9554-eaeb-4694-8089-00133fcadce3eslicarbazepine acetate 400 MG (7) / eslicarbazepine acetate 800 MG (7) PackPSN16These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 201320231110
3d0c9554-eaeb-4694-8089-00133fcadce3Titration Sample Pack (7 eslicarbazepine acetate 400 MG Oral Tablet / 7 eslicarbazepine acetate 800 MG Oral Tablet)SY16These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 201320231110